Janet Gunzner-Toste

Author PubWeight™ 6.95^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Ser1292 autophosphorylation is an indicator of LRRK2 kinase activity and contributes to the cellular effects of PD mutations.	Sci Transl Med	2012	1.62
2	Potent and selective aminopyrimidine-based B-Raf inhibitors with favorable physicochemical and pharmacokinetic properties.	J Med Chem	2012	0.96
3	Discovery of highly potent, selective, and brain-penetrable leucine-rich repeat kinase 2 (LRRK2) small molecule inhibitors.	J Med Chem	2012	0.94
4	Discovery of selective LRRK2 inhibitors guided by computational analysis and molecular modeling.	J Med Chem	2012	0.90
5	Structure-based discovery of novel amide-containing nicotinamide phosphoribosyltransferase (nampt) inhibitors.	J Med Chem	2013	0.89
6	Structure-based identification of ureas as novel nicotinamide phosphoribosyltransferase (Nampt) inhibitors.	J Med Chem	2013	0.86
7	Fragment-based identification of amides derived from trans-2-(pyridin-3-yl)cyclopropanecarboxylic acid as potent inhibitors of human nicotinamide phosphoribosyltransferase (NAMPT).	J Med Chem	2014	0.81
8	Discovery of Peptidomimetic Antibody-Drug Conjugate Linkers with Enhanced Protease Specificity.	J Med Chem	2017	0.75